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Type 1 diabetes is a metabolic disorder caused by inadequate production of insulin in the 
body. Accordingly, patients with this 
disorder need daily insulin injections. 
Despite considerable scientific ad-
vances, the etiology of this disorder re-
mains unknown (1). Epidemiological 
studies have demonstrated that the 
prevalence of type 1 diabetes has in-
creased by 2–5% worldwide (2). In 
the United States, the prevalence of 
type 1 diabetes has been reported to 
be 1 per 300 Americans >18 years of 
age (1). The incidence of this disorder 
in our country, Iran, was 0.7 cases per 
100,000 Iranians in 2010 (3). 
Uncontrolled type 1 diabetes is 
associated with microvascular and 
macrovascular complications such as 
cardiovascular diseases, neuropathy, 
nephropathy, and retinopathy (4). 
Accordingly, rapid and proper man-
agement of diabetes is essential to the 
prevention of these complications. 
The primary aims of diabetes man-
agement are optimal blood glucose 
control and prevention of diabetes- 
associated complications (5). Poor 
blood glucose control and nonadher-
ence to treatment regimens can cause 
diabetes-associated complications, 
reduce patients’ quality of life (1), and 
increase health care costs (6).
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■ ABSTRACT
Background. Motivational interviewing (MI) is a strategy for promoting ad-
herence to treatment regimens among patients with diabetes. However, limit-
ed evidence exists regarding its effectiveness in reducing A1C. 
Objective. To identify and synthesize evidence about the effectiveness of 
patient, provider, and health system interventions to improve diabetes care 
among patients with type 1 diabetes.
Design. This was a systematic review of randomized controlled trials.
Methods. A search was conducted of the scientific databases MEDLINE, 
Elsevier, CINAHL, Google Scholar, ProQuest, Ovid, and PubMed without 
imposing any time limit. Only four documents met the inclusion criteria 
and were included in the final analysis. The methodological quality of these 
four articles was reviewed by three reviewers using the Jadad Scale. The main 
intervention and the primary outcome in this study were MI or motivational 
enhancement therapy and A1C, respectively.
Results. The retrieved studies reported that MI promotes self-monitoring 
of blood glucose and reduces A1C.
Conclusion. MI is effective in enhancing patients’ adherence to the treat-
ment regimen and thereby decreasing A1C. Given the fact that the reviewed 
studies had not eliminated the effects of confounding factors, further studies 
are needed to assess the pure effects of MI on adherence to treatment regimens 
and A1C levels.
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Many pharmacological therapies 
and nonpharmacological techniques 
have been developed for prevent-
ing the complications of diabetes, 
the latter of which include regular 
physical exercise, dietary regimens, 
stress management, smoking cessa-
tion, and motivational interviewing 
(MI). However, the effectiveness 
of these techniques and the success 
of diabetes management strategies 
depend largely on their accordance 
with patients’ preferences and val-
ues, as well as patients’ adherence to 
them (7–9). The process of diabetes 
management is lengthy and laborious, 
and, hence, patients have low motiva-
tion for adhering to their prescribed 
dietary and treatment regimens (5). 
Accordingly, they need to be sup-
ported and motivated throughout the 
process of treatment.
MI is one nonpharmacological 
strategy for diabetes management and, 
particularly, for motivating patients to 
closely adhere to prescribed regimens 
(10). MI helps patients accept their 
disease, modify their lifestyle, correct 
their misconceptions, and overcome 
psychological problems such as 
depression (11–14). MI intervention-
ists are generally trained as health 
psychologists. The MI interviewing 
intervention uses a “menu of strate-
gies” approach (15), eliciting patient 
views and then exploring discrepan-
cies between beliefs and behavior.
Although no two MI sessions will 
be the same because they are patient 
driven, they are likely to include the 
following aspects. The clinician’s role 
is to help patients articulate their 
simultaneously held but conflicting 
beliefs about behavioral change. In 
making decisions about changing 
behavior, individuals weigh the ben-
efits of making a change against the 
personal costs, which may be social, 
emotional, or financial; their ambiv-
alence about making the change 
reflects the balance of the benefits 
and costs. The clinician’s role is to 
elicit benefits and costs and increase 
patients’ awareness of them. Once 
patients are more aware of the costs 
and benefits of their behaviors, alter-
natives to their current behaviors 
can be considered. Having identified 
alternative behaviors, the costs and 
benefits of the alternative options are 
then discussed. The choice of which 
alternative behavior to adopt rests 
with the patient. Once an alterna-
tive behavior has been selected, the 
clinician and patient set a goal that 
is realistic and achievable in the time 
between appointments.
One of the central tenets of MI is 
avoidance of confrontation to reduce 
resistance and argumentation (16). 
Instead, the conversational style is 
one of eliciting by asking open-ended 
questions to encourage participants 
to articulate their concerns and goals.
Previous studies have shown that 
MI has positive effects on adherence 
to treatment regimens among ado-
lescents with type 1 diabetes (16). 
However, considerable controversies 
exist concerning the effectiveness of 
MI and motivational enhancement 
therapies (METs) in decreasing A1C. 
Previous studies in this area differ 
from each other in terms of sampling 
method, length of intervention, and 
follow-up care. Accordingly, this sys-
tematic review study was conducted 
to provide clear evidence regarding 
the effects of MI on adherence to 
treatment regimens among patients 
with type 1 diabetes.
Methods
The Preferred Reporting Items for 
Systematic Reviews (PRISMA) guide-
lines were used to standardize the con-
duct and reporting of the research.
Data Collection
We searched the online scientific data-
bases MEDLINE, Elsevier, CINAHL, 
Google Scholar, ProQuest, Ovid, and 
PubMed. Moreover, a paper-based 
search was performed simultaneous-
ly on accessible library records. No 
time limit was defined. The initial 
search term “type 1 diabetes” pro-
duced 64,568 articles. After limiting 
the search protocol by using addition-
al search terms such as “motivational 
interviewing” and “motivational en-
hancement therapy,” and “randomized 
controlled trial,” the number of docu-
ments was decreased to 2,243. Then 
the term “HgbA1c” was added, and 
the total number of articles decreased 
to 24, which were then anonymized 
and given to three independent re-
viewers to be evaluated. Inclusion cri-
teria were that the articles had to have 
been published in English and had to 
address the effects of MI on adherence 
to treatment regimens among patients 
with type 1 diabetes. Articles were ex-
cluded if they dealt with investigating 
the effects of MI on other parameters 
or other patient populations, focused 
on A1C assessment in patients with ei-
ther type 1 or type 2 diabetes without 
differentiating between them, or had a 
score of <3 on the Jadad Scale, a valid 
tool for evaluating the methodologi-
cal quality of randomized, controlled 
trials (RCTs) (17). The three reviewers 
separately evaluated the documents us-
ing the Jadad Scale, which rates RCTs 
based on randomization, blinding, and 
dropout rate. The maximum possible 
Jadad score is 5. Only articles that had 
a Jadad score of ≥3 were included. Of 
the 24 articles, 10 were rejected for 
meeting exclusion criteria, 5 were re-
jected for not meeting inclusion cri-
teria, and 5 could not be retrieved; 
thus, only 4 articles were included in 
the final analysis (Figure 1). 
A data sheet was developed for 
retrieving the relevant information 
from these four articles. The data 
sheet included details about the type 
of study, sample size, mean age of 
participants, main and follow-up 
interventions, and primary outcomes. 
The main intervention was either MI 
or MET, both of which are defined 
as treatment techniques for enhancing 
individuals’ motivation or readiness to 
modify their behavior (12,18,19). The 
main outcome was A1C. Table 1 sum-
marizes the data extracted from the 
analyzed studies. 
Ethical Considerations
This project was registered at the 
Nursing and Midwifery Care Re-
search Center of Tehran University 
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of Medical Sciences, registration 
number of 25353. Rules regarding 
ethical issues (including plagiarism, 
informed consent, misconduct, data 
fabrication and/or falsification, dou-
ble publication and/or submission, 
and redundancy) were fully followed 
by the authors.
Results
The four studies included in the anal-
ysis are described in the paragraphs 
below.
In 2003, Channon et al. (18) con-
ducted a pilot study in the United 
Kingdom to investigate the effects of 
MI as a behavior-change counseling 
approach to blood glucose control, 
well-being, and self-care among ado-
lescents with type 1 diabetes. They 
found a significant decrease in A1C 
from 10.8 to 9.7% after the inter-
vention. In addition, they found 
that their intervention alleviated 
adolescents’ fear of developing hypo-
glycemia (P = 0.03) and made living 
with diabetes easier for them (P = 
0.03). Their findings also showed that 
MI could be useful in helping ado-
lescents monitor their blood glucose 
more effectively. Most of the par-
ticipating adolescents reported that 
they experienced at least one change 
in their self-care behavior during the 
course of the study.
After completing their pilot 
study, Channon et al. designed and 
conducted an RCT, which they 
reported in 2007 (19). The results of 
this study revealed that, after 12 and 
24 months, mean A1C in the exper-
imental group (8.7 ± 1.84% and 8.7 ± 
1.88%, respectively) were significantly 
lower than in the control group (9.2 ± 
1.78% and 9.1 ± 1.51%, respectively; 
P = 0.04 and P = 0.003, respectively).
The third study was a three-group 
RCT conducted by Ismail et al. and 
reported in 2008 (20) on 344 adult 
patients who had had type 1 diabetes 
for at least 2 years. Before implement-
ing the intervention, participants’ A1C 
ranged from 8.2 to 15.0%, and patients 
had not developed any diabetes- 
related complications. Patients in 
the first experimental group received 
a four-session nurse-implemented 
MET program over 2 months, and 
those in the second experimental 
group received both cognitive behav-
ior therapy (CBT) and MET, which 
were delivered in 12 sessions over 6 
months. Patients in the control group 
were treated with routine care, which 
did not include CBT or MET. Twelve 
months after the intervention ended, 
A1C levels were re-tested, and the A1C 
levels of the two experimental groups 
differed significantly from each other 
(P = 0.01) so that A1C levels in the 
group that received both MET and 
CBT were significantly less than in 
the group that received only MET and 
also than the control group (P <0.05). 
The final study was a 2013 pilot 
study by Stanger et al. (21), involving 
17 adolescents with type 1 diabetes 
who were 12–17 years of age. The 
adolescents and their parents received 
a multicomponent intervention con-
■ FIGURE 1. Flow diagram of literaure search.
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sisting of MI, CBT, parent-directed 
contingency management (CM), and 
clinic-based CM over 14 weeks. MI 
and CBT included education about 
self-care behaviors, the basics of estab-
lishing effective communications, and 
the antecedents and consequences of 
poor blood glucose control, as well as 
problem-solving, mood control, and 
anger management skills. This educa-
tion was provided through interviews. 
CM consisted of education to reinforce 
adolescents’ glucose monitoring behav-
ior to gradually increase the number 
of glucose monitoring tests to 6 times/
day, 5 days/week. Parent-directed CM 
included parental support to reinforce 
adolescents’ glucose monitoring behav-
ior. In addition to offering support, the 
parents were educated and required to 
directly supervise their adolescents’ 
glucose monitoring behavior. The 
aim of all these interventions was to 
promote better blood glucose control 
among the adolescents. The findings 
revealed that the number of glucose 
monitoring tests increased significantly 
from 4 to 6 times/day (P <0.001). 
Moreover, the adolescents’ mean A1C 
decreased significantly from 11.6 to 
9.11% (P <0.0001).
Discussion
Four RCTs met the inclusion criteria 
and were included in our analysis. All 
four investigated the effects of MI or 
MET on A1C among patients with 
type 1 diabetes, and all of their find-
ings indicated the effectiveness of MI 
or MET in reducing A1C. However, 
these four studies differed significant-
ly from each other with regard to the 
degree to which their interventions 
changed A1C. Given the heteroge-
neity of the types and the lengths of 
the interventions, we did not perform 
statistical analysis on the differences 
among these studies. 
Channon et al. (18) noted that 
their findings need to be interpreted 
cautiously because their study was a 
short-term, small-scale, uncontrolled 
pilot experiment. Accordingly, the 
experimental group was not compared 
to a control group or a placebo condi-
tion. In this study, a slight change in 
adolescents’ self-care behaviors signifi-
cantly reduced A1C. Given the small 
sample size of this study, however, 
controlling for adolescents’ psycho-
logical stress, psychosocial status, and 
TABLE 1. Characteristics of Studies Included in the Analysis
OutcomesFollow-Up, 
months
InterventionsPopulation  
(Sample Size)
Study 
Design
First Author 
(Year)
Mean A1C decreased from 
10.8 to 9.7%
6The initial training in MI for  
researchers took place over 
a 3-month period using a 
combination of workshop, 
training videos, role play, and 
individual supervision
Individuals 
ages  
14–18 years  
(n = 22)
Pilot 
study 
RCT
Channon et 
al. (2003) (18)
At the end of the interven-
tion (12 months), the mean 
A1C in the MI group was 
significantly lower than in the 
control group (P = 0.04), after 
adjusting for baseline values. 
At 24 months (when n = 47), 
this difference in A1C was 
maintained (P = 0.003). 
12–24MI, through which patients’ 
views were elicited and dis-
crepancies between beliefs 
and behavior were explored
Individuals 
ages 
14–17 years 
(total n = 66; 
intervention 
group 
n = 38; control 
group n = 28)
RCTChannon et 
al. (2007) (19)
The mean 12-month A1C was 
0.45% lower in those treated 
with MET plus CBT than for 
those receiving usual care; 
0.16% lower in those treated 
with MET than for those re-
ceiving usual care; and 0.30% 
lower with MET plus CBT than 
with MET alone.
12Four sessions of MET over 2 
months; 12 sessions of MET 
plus CBT over 6 months
Adults 
(n = 344)
RCTIsmail et al. 
(2008) (20)
A1C was significantly lower  
at the end of treatment 
compared with before 
treatment (before-treatment 
least square mean [LSM] 
11.62% [95% CI 10.75–12.48%]; 
post-treatment LSM 9.11% 
[95% CI 8.25–9.98%]; t(29) = 
5.15, adjusted P <0.0001,  
drm = 1.25).
314 weeks of MI and CBT,  
clinic-based CM, and  
parent-directed CM target-
ing increased blood glucose 
monitoring
Individuals 
ages 
12–17 years 
(n = 17)
 Pilot 
study
Stanger et 
al. (2013) (21)
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treatment regimens was not possible. 
Moreover, the instrument used to 
measure adolescents’ self-care activ-
ities might have not been sensitive 
enough to detect probable behavioral 
changes. Accordingly, if the research-
ers had employed a more sensitive 
instrument and evaluated the behav-
ioral outcomes of MI in shorter time 
intervals, they might have acquired 
different results. 
In their second study (19), 
Channon et al. matched the two 
groups with regard to demographic 
characteristics such as age, dura-
tion of diabetes, ethnicity, sex, and 
socioeconomic status. Although they 
tried to match demographic vari-
ables, the observed outcomes could 
have been the result of not only the 
intervention, but also the effects of 
the researchers. Most dropouts (10 
from the experimental group and 4 
from the control group) occurred in 
the first 6 months of the intervention. 
However, the two groups did not dif-
fer significantly with regard to the 
total number of dropouts (P = 0.24), 
indicating that the characteristics of 
the groups remained unchanged after 
the dropouts.
The findings of this study revealed 
that MI can facilitate behavior 
change, promote blood glucose con-
trol, and improve mental health and 
quality of life among adolescents 
with type 1 diabetes. Because of the 
long-term course of the interven-
tion (24 months), the results of this 
study are more reliable. However, the 
findings may have been affected not 
only by MI, but also by changes in 
adolescents’ behaviors and self-care 
practices. Moreover, adolescents’ 
insulin regimens, which might 
have affected their A1C, were not 
evaluated.
The results of the second study 
by Channon et al. (19) showed an 
increase, albeit a statistically nonsig-
nificant one, in A1C in the control 
group during the first 6 months, with 
a return to baseline A1C levels after 1 
year. The mean A1C concentrations 
between the two groups were signifi-
cantly different (F = 4.276, P = 0.04) 
at the end of the year-long interven-
tions, after adjusting for baseline. A 
possible explanation for this increase 
is a seasonal effect given that this data 
period coincided with winter, when 
glycemic control is known to deterio-
rate in children, presumably because 
of decreased levels of physical activ-
ity. Changes in certain psychological 
variables such as well-being, quality 
of life, and personal models of illness 
as secondary outcomes were found 
between groups after 12 months 
(all P <0.001). Changes on key psy-
chosocial measures were related to 
improvements in A1C. Although 
cause and effect cannot be assumed, 
if psychological factors were to affect 
A1C, it might be anticipated that 
such psychological changes would 
precede changes in self-care, which 
consequently led to changes in A1C. 
Our analysis suggests that MI might 
highlight concerns but also facilitate 
patients’ perception that they have the 
capacity to make changes, which in 
turn could lead to reductions in A1C. 
The MI method incorporates the 
principle of “deploying discrepancy,” 
which means contrasting through 
empathic listening the patients’ core 
values and personal aspirations with 
the behavioral problem under dis-
cussion. It is hypothesized that this 
experience of discrepancy could trig-
ger the motivation to change behavior.
In the third study, conducted by 
Ismail et al. (20), a nurse-implemented 
MET program facilitated improved 
control of serum glucose and A1C. 
Moreover, the authors reported that 
their MET program exerted more 
powerful effects on blood glucose and 
A1C when combined with CBT.
The fourth study, by Stanger et al. 
(21), was also a pilot without a con-
trol group. Six months after the end of 
the intervention, there was no signifi-
cant difference in A1C between teens 
receiving the intervention and those 
getting usual care. Despite the limited 
change in A1C, the intervention con-
dition showed significant reductions 
in hospitalization for ketoacidosis, 
although the confounding effects of 
variables such as age, sex, ethnicity, 
socioeconomic status, and baseline 
A1C were not evaluated or removed.
A1C values should be obtained 
using the same measure. However, 
because this pilot study relied on clin-
ical testing, this was not possible for 
all tests; for 4 of 48 tests, a laboratory 
blood test was used instead. In addi-
tion, the intervention was intensive, 
requiring weekly clinic visits over an 
extended period of time. Finally, A1C 
did not reach the American Diabetes 
Association target, and it will be 
important to demonstrate mainte-
nance of positive effects over time.
Conclusion
This systematic review adds to the ev-
idence regarding the effectiveness of 
interventions that target people with 
type 1 diabetes in community set-
tings. Study findings suggest that MI 
is effective in promoting adherence 
to treatment regimens and decreasing 
A1C among patients with type 1 di-
abetes. Moreover, it can facilitate the 
modification of self-care and self-man-
agement behaviors among adolescents 
with the disease.
This evidence shows the positive 
effects of psychosocial interventions 
such as MI. It is noteworthy that the 
reviewed studies did not take into 
account factors such as patients’ mood, 
psychological state, treatment regi-
men, support system, and stress levels 
that could have confounding effects 
on A1C. Accordingly, further studies 
are needed to assess the pure effects 
of MI on adherence to treatment reg-
imens and A1C. A meta-analysis of 
individual patient data may answer 
further questions that could not be 
addressed in this review.
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